Intellectual Property (IP) Waterproofing., page-24

The benefit of a clinical history and a compound developed when broadness of activity was the goal. Most drugs developed today are highly specialized to a gene or protein. Bisantrene is one of the most sensitive agents I have seen because of how broadly targeting it is. Wonder what happens when you use it properly.

Here are the tumor agnostic approved drugs.

Tumor Agnostic Therapies Drug Name

Larotrectinib (Vitrakvi)

Entrectinib (Rozlytrek)

Repotrectinib (Augtyro)

Pembrolizumab (Keytruda)

Dostarlimab (Jemperli)

Dabrafenib and Trametinib (Tafinlar & Mekinist)

Selpercatinib (Retevmo)

Fam-trastuzumab deruxtecan (Enhertu)